Novartis Earnings Top, Sales Miss; NVS Stock Falls

Novartis Earnings Top, Sales Miss; NVS Stock Falls

Novartis earnings beat third-quarter views while sales came in light. Full-year revenue guidance was in line for the Swiss drug giant. Shares fell.